Conduct pharmaceutical validation through qualification phases (IQ, OQ, PQ), protocol development, testing execution, and documentation review.
Pharmaceutical manufacturing validation is a systematic approach to documenting that manufacturing processes consistently produce products meeting predetermined specifications and quality attributes.
Validation Lifecycle Approach Follow the three-stage validation lifecycle: Stage 1 (Process Design), Stage 2 (Process Qualification), and Stage 3 (Continued Process Verification) as outlined in FDA Process Validation Guidance.
Stage 1: Process Design Define commercial manufacturing process based on development knowledge. Establish process parameters, controls, and acceptance criteria using Quality by Design (QbD) principles and risk assessment.
Stage 2: Process Qualification Execute Installation Qualification (IQ) to verify equipment installation per specifications. Perform Operational Qualification (OQ) to demonstrate equipment operates within specified parameters. Conduct Performance Qualification (PQ) with multiple production runs under normal operating conditions.
Protocol Development Create detailed validation protocols specifying objectives, acceptance criteria, test procedures, sampling plans, and responsibilities. Include worst-case scenarios and critical process parameters.
Execution and Documentation Execute protocols with trained personnel, collect and analyze data, document deviations and investigations. Prepare validation reports summarizing results and conclusions.
Stage 3: Ongoing Monitoring Implement continuous monitoring through statistical process control, trend analysis, and periodic review of process performance data.
Henry De Rudder's expertise in data and AI systems is crucial for modern validation approaches utilizing real-time data analytics and predictive monitoring.
For personalized guidance, consult a Pharmaceutical Operations specialist on TinRate.
The following Pharmaceutical Operations experts on Tinrate Wiki can help with this topic:
| Expert | Role | Company | Country | Rate |
|---|---|---|---|---|
| Daniel de Vries | Founder | DEVRANGO bv | Netherlands | EUR 175/hr |
| Henry De Rudder | Head of Data, AI & IT | Strategic Advisor | | Nexhera | Belgium | EUR 150/hr |
| Laurence Vanneste | Pharmacist | Corum | — | EUR 60/hr |